Steward Partners Investment Advisory, LLC Myriad Genetics Inc Call Options Transaction History
Steward Partners Investment Advisory, LLC
- $12.3 Billion
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding MYGN
# of Institutions
233Shares Held
93.7MCall Options Held
450KPut Options Held
14.2K-
Black Rock Inc. New York, NY15.2MShares$91.4 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.26MShares$55.8 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny4.92MShares$29.7 Million0.01% of portfolio
-
State Street Corp Boston, MA4.81MShares$29 Million0.0% of portfolio
-
Glenview Capital Management, LLC New York, NY4.59MShares$27.7 Million0.69% of portfolio
About MYRIAD GENETICS INC
- Ticker MYGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 80,634,800
- Market Cap $486M
- Description
- Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...